Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Does using a CGM for weight loss work? Not reliably on its own. A continuous glucose monitor shows how your blood sugar rises and falls through the day, and some small trials suggest that seeing the numbers can nudge eating habits, but the larger evidence has not shown a clear effect on body weight. I am not a clinician, so this page sticks to what the sources report.
My guide to the best weight loss programs for women over 40 shows where a sensor fits next to coaching, medication and food-focused plans.
Does using a CGM for weight loss actually work?
The research is thin and mixed. A 2024 systematic review pooled 25 randomized trials with 2,996 participants that gave CGM feedback to one group and not to a comparison group. Most trials enrolled adults with type 2 diabetes, three enrolled adults with obesity, 44 percent reported links to CGM makers, and the pooled effect on weight and BMI was not statistically significant. HbA1c, the blood test that reflects average blood sugar over about three months, did improve by 0.28 percentage points, which says little about weight loss.
A 2026 systematic review looked only at adults without diabetes who could see their own readings. It found 12 studies, rated the certainty of the evidence low to very low, and concluded that a CGM may support some dietary changes inside a structured program while large, durable benefits and stand-alone effectiveness are not established. Johns Hopkins researcher Michael Fang said in January 2026 that no major trials have tried to show health benefits for adults without diabetes.
What the trials enrolled and what they found
| Source | Who was studied | What it reported | Limit |
|---|---|---|---|
| 2024 review of 25 trials | 2,996 adults, mostly type 2 diabetes | No significant effect on weight or BMI; small gain in time in range | Few trials in people without diabetes |
| 2026 review, adults without diabetes | 12 studies | Possible dietary changes; one 8-week trial found 15.2 g less carbohydrate intake with CGM plus education than with education alone | Low to very low certainty |
| 12-week randomized trial | 35 women with overweight or obesity | Weight fell 5.5 kg in the CGM-feedback group versus 0.2 kg in controls | Tiny sample; both groups did supervised exercise and diet counseling |
The 12-week trial is the most encouraging result for women. Both groups trained three times a week and got the same diet counseling; one group also wore a scanning sensor mid-study. Fewer than 20 women per group cannot tell us what you will see, and the authors call for larger, longer studies.
What is a CGM and what does it measure?
A continuous glucose monitor is a small sensor, often worn on the arm, that estimates your glucose levels every few minutes and sends them to a phone app. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) explains that sensors estimate the glucose in the fluid between your cells, which is very similar to the glucose in your blood, and that a doctor may recommend a CGM if you need insulin to manage diabetes.
How accurate are over-the-counter CGMs?
Good on trends, weaker on exact numbers. A 2026 study tested over-the-counter CGMs in 39 young adults without diabetes against fingerstick blood sugar readings. Average error was 12.9 percent, and 66.5 percent of readings landed within 15 percent or 15 mg/dL of the meter. Agreement was worse after a sugary drink (15.3 percent error versus 10.6 percent after a placebo drink), and the sensor lagged by about six minutes. The authors say the devices may help with lifestyle monitoring but warrant caution for diagnostic thresholds.
Which CGMs can you buy without a prescription?
Stelo, Lingo and Signos are three FDA-cleared consumer systems for adults who do not use insulin. The FDA cleared the Dexcom Stelo on March 5, 2024 as the first over-the-counter CGM, for anyone 18 or older who does not use insulin, including people without diabetes who want to see how diet and exercise affect blood sugar. Abbott announced clearance of Lingo on June 10, 2024. The FDA’s 510(k) database lists the Signos Glucose Monitoring System as cleared on March 21, 2025, and CNBC reported the company’s announcement on August 20, 2025.
| System | Indicated for (per FDA or maker) | What the page says you get | Price read 2026-10-28 |
|---|---|---|---|
| Dexcom Stelo | Adults 18 and older not on insulin; not for problematic hypoglycemia | Sensor worn up to 15 days (FDA), app with built-in coaching | Monthly subscription listed at $89.00 (the page also shows $99.00) |
| Abbott Lingo | Adults 18 and older not on insulin; not intended to diagnose disease | One biosensor, up to 14 days, full app access | $54 for a 2-week plan that does not auto-renew |
| Signos | Adults 18 and older not on insulin; indication says the information may help users maintain a healthy weight | Membership with hardware included | $127 per month membership |
Two cautions. The Stelo indication says not to take medical action based on the readings without talking to a qualified health professional, and the FDA says the Stelo is not for people with problematic hypoglycemia because it is not designed to alert you to dangerously low blood sugar. Clearance is not a finding that a sensor improves health: Fang told Johns Hopkins that whether the devices improved health outcomes was not a factor in the FDA decision, and the FDA’s Stelo release says only that clinical data showed the device performed similarly to other integrated CGMs.
What do normal blood sugar levels look like without diabetes?
They move more than most of us expect. In a multicenter study of 153 healthy, non-obese people aged 7 to 80 who wore a blinded Dexcom G6 for up to 10 days, average glucose was 98 to 99 mg/dL in every age group except those over 60, who averaged 104. Participants spent a median of 96 percent of the time between 70 and 140 mg/dL, a median of 2.1 percent above 140 (about 30 minutes a day) and a median of 1.1 percent below 70 (about 15 minutes a day).
That study excluded people with obesity, so treat it as a benchmark and not a pass or fail line. Diagnosis rests on lab tests. NIDDK lists a fasting plasma glucose of 99 mg/dL or below as normal, 100 to 125 as prediabetes and 126 or above as diabetes, and an A1C below 5.7 percent as normal. NIDDK adds that you should not try to diagnose yourself and that a home glucose meter cannot diagnose diabetes.
Is a blood sugar spike bad for weight loss?
A spike on your screen is not a verdict on a food. In a 2015 study published in Cell, researchers monitored 800 people for a week and recorded responses to 46,898 meals. They found high variability in the response to identical meals and concluded that universal dietary recommendations may have limited utility. Your sensor shows your response to one meal on one day.
Johns Hopkins epidemiologist Elizabeth Selvin said a healthy person probably has some spikes regularly, and that tracking them too closely can cause unnecessary anxiety about occasional high readings. She also said improving metabolic health, which consumer CGMs claim to do, is much more complicated than avoiding the foods that trigger spikes. Fang added that in people without diabetes we do not really know how to act on differing glucose patterns.
Marketing copy often goes further. Signos says on its page that frequent spikes shift the body into “storage mode.” None of the trials above tested that idea about body fat.
What can a CGM show, and what can it not tell you?
| A CGM can show | A CGM cannot tell you |
|---|---|
| How your blood sugar rose and fell after a meal on a given day | Whether that meal is healthy or will make you gain weight |
| Patterns across the wear period, such as time between 70 and 140 mg/dL | Whether you have prediabetes or diabetes; NIDDK says lab tests diagnose these |
| An estimate of glucose in the fluid between your cells | Your exact blood glucose; over-the-counter sensors averaged 12.9 percent error in one study |
| How exercise lines up with your readings | Your cholesterol, triglycerides or sodium intake; the Johns Hopkins article says people who focus too much on glucose readings may ignore these |
| A smaller rise after a food swap | Whether the swap is a good trade; Selvin’s example is sausage instead of an orange, which may raise glucose less and is not necessarily healthier |
What does a CGM cost and what happens to your data?
Prices in the table were read on each maker’s page on October 28, 2026, and they change. Stelo and Signos both list their products as HSA and FSA eligible, and CNBC reported in August 2025 that insurers did not cover the Signos system for weight management.
Blood sugar readings are health information, so read the privacy terms first. Dexcom’s privacy notice, last updated July 2024, lists health information among the data it may collect and says that, depending on your state, you may be able to limit or opt out of the sale of personal data or its use for targeted advertising.
Who should skip a CGM or ask a clinician first?
The cleared systems are indicated for adults 18 and older who are not on insulin. In the clinical study the FDA described for the Stelo, adverse events included local infection, skin irritation and pain or discomfort, and NIDDK notes that the sticky patch can cause skin redness or irritation.
Lingo’s page asks anyone with an eating disorder or a history of one to consult a healthcare professional before changing diet or exercise. That fits Selvin’s warning about anxiety over normal readings. If your real worry is diabetes or prediabetes, Selvin said the way to find out is screening with lab tests such as glucose and HbA1c. Fang suggested that wearing a sensor once or twice may be enough to see how foods affect your blood sugar.
How could a CGM fit into a weight loss plan?
As a feedback tool inside a plan, not as the plan. In the studies above, the CGM groups were also getting structured education, counseling or supervised exercise. For that kind of structure, see what suits your eating pattern in best diets for women over 40 and read how hormone changes affect weight in weight loss during menopause. Walking for weight loss is a low-cost place to start.
Medical note: this page reports published research and maker information and is not medical advice. I am not a medical professional. Talk with your prescriber or pharmacist before using a glucose sensor if you take insulin, prescription medicine or another diabetes medicine, if you are pregnant or nursing, or if you have a history of disordered eating.
Frequently Asked Questions
Can you get a CGM without diabetes?
Yes. The FDA cleared the Stelo as an over-the-counter CGM for adults 18 and older who do not use insulin, including those without diabetes, and Lingo and Signos carry similar indications. None is cleared for diagnosing a condition.
Does the sensor hurt, and how long does it last?
Lingo’s page describes applying the sensor as painless, while the clinical study the FDA described for the Stelo lists local infection, skin irritation and pain or discomfort among the adverse events. The FDA says a Stelo sensor can be worn up to 15 days, and Stelo’s page says 77.9 percent of sensors in its test lasted the full 15 days. Lingo’s page says up to 14 days.
Can a CGM tell me if I have insulin resistance or prediabetes?
No. Lingo says its system is not intended for the diagnosis of diseases, including diabetes, and NIDDK says diagnosis uses blood tests such as fasting glucose and A1C. A clinician decides what tests to order.
Is a CGM a good idea if I have a history of disordered eating?
Lingo’s page tells people with an eating disorder or a history of one to consult a healthcare professional first. Johns Hopkins researchers also warned that tracking readings too closely can cause anxiety.
Sources
- FDA 510(k) database, K250106, Signos Glucose Monitoring System (decision March 21, 2025)
- FDA news release, FDA Clears First Over-the-Counter Continuous Glucose Monitor (March 5, 2024)
- NIDDK, Continuous Glucose Monitoring (last reviewed June 2023)
- NIDDK, Diabetes Tests and Diagnosis (last reviewed July 2022)
- PubMed, efficacy of CGM as a behaviour change tool, systematic review and meta-analysis of randomised controlled trials (2024)
- PubMed, participant-visible CGM in adults without diabetes, systematic review (2026)
- PubMed, intermittently scanned CGM in women with obesity, randomized trial (2026)
- PubMed, agreement of over-the-counter CGMs with capillary glucose (2026)
- PubMed, CGM profiles in healthy nondiabetic participants (2019)
- PubMed, Personalized Nutrition by Prediction of Glycemic Responses (Cell, 2015)
- Johns Hopkins Bloomberg School of Public Health, Are Glucose Monitors Useful for People Who Don’t Have Diabetes? (January 28, 2026)
- Stelo by Dexcom, product page (read October 28, 2026) and Dexcom privacy notice
- Lingo by Abbott, product page (read October 28, 2026) and Abbott press release (June 10, 2024)
- Signos, product page (read October 28, 2026) and CNBC, August 20, 2025